In addition, circulating microRNAs recently detected in TGCT patients demonstrate higher sensitivity (87–96%) and specificity (99%) in seminoma and NSGCT than AFP and β‐hCG combined (about 60%), which are often negative in seminoma and teratoma.12, 13. Here, AFP is linked to seminoma.